Rune labs and medtronic partner to evaluate use of medtronic brainsense™ data in rune's software for precision neurology

San francisco, nov. 2, 2021 /prnewswire/ --  rune labs , a company using aggregated brain data to empower the development and delivery of precision medicines for neurological and psychiatric diseases, and medtronic plc  (nyse:mdt), a global leader in healthcare technology, today announced a new project designed to better understand the effects of neurostimulation in order to improve patient care. this collaboration will use rune's proprietary software platform to integrate, analyze, and display data captured from medtronic's percept™ pc neurostimulator, along with data from the strivepd apple watch application and other sources.
MDT Ratings Summary
MDT Quant Ranking